1. DISCLAIMER This slide deck in its original and unaltered format is for educational purposes and is current as of September 2012. All materials contained herein reflect…
1.PERJETA® is a first-line treatment for HER2positive metastatic breast cancer. • PERJETA is an FDA-approved treatment for HER2-positive metastatic breast cancer. It is…